Unspecified microbial and biofilm components

Unspecified microbial and biofilm components refer to the collective structural and functional elements that constitute a microbial biofilm, including the extracellular polymeric substances (EPS) matrix (National Institutes of Health, 2021). Biofilms are complex, multicellular communities of microorganisms—such as bacteria or fungi—that adhere to surfaces and are encased in a self-produced matrix composed of polysaccharides, proteins, lipids, and extracellular DNA (eDNA) (Nature Reviews Microbiology, 2010). This matrix provides a robust physical barrier that protects the embedded microbes from host immune defenses and significantly increases resistance to conventional antimicrobial therapies by limiting drug penetration (StatPearls, 2023). In clinical settings, biofilms are major contributors to chronic and persistent infections, particularly those involving medical implants, chronic wounds, and the respiratory tract of patients with cystic fibrosis (Journal of Clinical Medicine, 2020). Therapeutic strategies targeting these components aim to disrupt the matrix integrity, degrade its structural molecules, or inhibit the signaling pathways, such as quorum sensing, that regulate biofilm formation and maintenance (Frontiers in Microbiology, 2019). By breaking down these unspecified components, drugs can enhance the penetration of standard antibiotics and facilitate the clearance of otherwise recalcitrant infections.

Other names

Microbial biofilmExtracellular polymeric substancesEPS matrixBiofilm-associated componentsMicrobial community structure

Drugs targeting these components typically act by enzymatically degrading the extracellular matrix (e.g., via DNases that target eDNA or glycoside hydrolases that target polysaccharides), inhibiting the synthesis of matrix components, or physically disrupting the microbial community structure to restore antibiotic sensitivity and facilitate immune clearance (PubMed, PMID: 30245177).